• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病肾病发病过程中的免疫受体库和进化轨迹分析。

Immune repertoire and evolutionary trajectory analysis in the development of diabetic nephropathy.

机构信息

Department of Endocrinology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.

State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing, China.

出版信息

Front Immunol. 2022 Sep 23;13:1006137. doi: 10.3389/fimmu.2022.1006137. eCollection 2022.

DOI:10.3389/fimmu.2022.1006137
PMID:36211355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9537376/
Abstract

Diabetic nephropathy (DN) is the leading cause of death and the greatest risk to the lives of people with advanced diabetes. Yet, the molecular mechanisms underlying its development and progression remain unknown. In this research, we studied the primary pathways driving DN using transcriptome sequencing and immune repertoire analysis. Firstly, we found that the diversity and abundance of the immune repertoire in late DN were significantly increased, while there was no significant change in early DN. Furthermore, B cell-mediated antibody responses may be the leading cause of DN progression. By analyzing master regulators, we found the key DN-driving transcription factors. In the late stage of DN, immune cells, fibroblasts, and epithelial cells were abundant, but other stromal cells were few. Early DN kidneys had a higher tissue stemness score than normal and advanced DN kidneys. We showed that DN progression involves proximal tubular metabolic reprogramming and stemness restoration using Monocle3. Through WGCNA, we found that co-expression modules that regulate DN progression and immune repertoire diversity mainly regulate immune-related signaling pathways. In addition, we also found that early DN had apparent activation of immune-related signaling pathways mainly enriched in immune cells. Finally, we found that activation of fibroblasts is typical of early DN. These results provide a research basis for further exploring the molecular biology and cellular mechanisms of the occurrence and development of DN and provide a theoretical basis for the prevention and treatment of DN.

摘要

糖尿病肾病(DN)是导致糖尿病患者死亡的主要原因,也是其生命健康的最大威胁。然而,其发病和进展的分子机制尚不清楚。本研究通过转录组测序和免疫受体库分析,研究了导致 DN 的主要途径。首先,我们发现晚期 DN 中免疫受体库的多样性和丰度显著增加,而早期 DN 则没有明显变化。此外,B 细胞介导的抗体反应可能是 DN 进展的主要原因。通过分析主要调控因子,我们发现了关键的 DN 驱动转录因子。在 DN 的晚期阶段,免疫细胞、成纤维细胞和上皮细胞丰富,但其他基质细胞较少。早期 DN 肾脏的组织干性评分高于正常和晚期 DN 肾脏。我们通过 Monocle3 显示,DN 进展涉及近端肾小管的代谢重编程和干性恢复。通过 WGCNA,我们发现调节 DN 进展和免疫受体库多样性的共表达模块主要调节免疫相关信号通路。此外,我们还发现早期 DN 中明显激活了免疫相关信号通路,主要富集在免疫细胞中。最后,我们发现早期 DN 中存在典型的成纤维细胞激活。这些结果为进一步探索 DN 的发生发展的分子生物学和细胞机制提供了研究基础,并为 DN 的防治提供了理论依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef12/9537376/d124ae5b9552/fimmu-13-1006137-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef12/9537376/ec1758a89948/fimmu-13-1006137-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef12/9537376/1c0b858d6558/fimmu-13-1006137-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef12/9537376/254b04bd28bf/fimmu-13-1006137-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef12/9537376/380cdf8ef714/fimmu-13-1006137-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef12/9537376/be4075a79a64/fimmu-13-1006137-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef12/9537376/fa5e9dd58173/fimmu-13-1006137-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef12/9537376/a25af06278f5/fimmu-13-1006137-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef12/9537376/d124ae5b9552/fimmu-13-1006137-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef12/9537376/ec1758a89948/fimmu-13-1006137-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef12/9537376/1c0b858d6558/fimmu-13-1006137-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef12/9537376/254b04bd28bf/fimmu-13-1006137-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef12/9537376/380cdf8ef714/fimmu-13-1006137-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef12/9537376/be4075a79a64/fimmu-13-1006137-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef12/9537376/fa5e9dd58173/fimmu-13-1006137-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef12/9537376/a25af06278f5/fimmu-13-1006137-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef12/9537376/d124ae5b9552/fimmu-13-1006137-g008.jpg

相似文献

1
Immune repertoire and evolutionary trajectory analysis in the development of diabetic nephropathy.糖尿病肾病发病过程中的免疫受体库和进化轨迹分析。
Front Immunol. 2022 Sep 23;13:1006137. doi: 10.3389/fimmu.2022.1006137. eCollection 2022.
2
Identification of novel targets of diabetic nephropathy and PEDF peptide treatment using RNA-seq.利用RNA测序鉴定糖尿病肾病的新靶点及PEDF肽治疗
BMC Genomics. 2016 Nov 17;17(1):936. doi: 10.1186/s12864-016-3199-8.
3
Comparison of Kidney Transcriptomic Profiles of Early and Advanced Diabetic Nephropathy Reveals Potential New Mechanisms for Disease Progression.早期和晚期糖尿病肾病的肾脏转录组谱比较揭示了疾病进展的潜在新机制。
Diabetes. 2019 Dec;68(12):2301-2314. doi: 10.2337/db19-0204. Epub 2019 Oct 2.
4
Comprehensive analysis of diabetic nephropathy expression profile based on weighted gene co-expression network analysis algorithm.基于加权基因共表达网络分析算法的糖尿病肾病表达谱综合分析。
BMC Nephrol. 2021 Jul 2;22(1):245. doi: 10.1186/s12882-021-02447-2.
5
Targeting mammalian serine/threonine-protein kinase 4 through Yes-associated protein/TEA domain transcription factor-mediated epithelial-mesenchymal transition ameliorates diabetic nephropathy orchestrated renal fibrosis.通过 Yes 相关蛋白/TEA 结构域转录因子介导的上皮间质转化靶向哺乳动物丝氨酸/苏氨酸蛋白激酶 4可改善糖尿病肾病介导的肾纤维化。
Metabolism. 2020 Jul;108:154258. doi: 10.1016/j.metabol.2020.154258. Epub 2020 May 3.
6
Ferroptosis: a new strategy for Chinese herbal medicine treatment of diabetic nephropathy.铁死亡:中药治疗糖尿病肾病的新策略。
Front Endocrinol (Lausanne). 2023 Jun 9;14:1188003. doi: 10.3389/fendo.2023.1188003. eCollection 2023.
7
Deciphering the role of MicroRNAs in diabetic nephropathy: Regulatory mechanisms and molecular insights.解析 MicroRNAs 在糖尿病肾病中的作用:调控机制与分子见解。
Pathol Res Pract. 2024 Apr;256:155237. doi: 10.1016/j.prp.2024.155237. Epub 2024 Mar 4.
8
Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling.黄葵胶囊通过抑制 NLRP3 炎性小体激活和 TLR4/NF-κB 信号通路减轻糖尿病肾病肾小管上皮-间充质转化。
Phytomedicine. 2019 Apr;57:203-214. doi: 10.1016/j.phymed.2018.12.021. Epub 2018 Dec 17.
9
Activated YAP causes renal damage of type 2 diabetic nephropathy.活化的 YAP 导致 2 型糖尿病肾病的肾脏损伤。
Eur Rev Med Pharmacol Sci. 2019 Jan;23(2):755-763. doi: 10.26355/eurrev_201901_16890.
10
Genomic expression profiling and bioinformatics analysis on diabetic nephrology with ginsenoside Rg3.人参皂苷Rg3对糖尿病肾病的基因表达谱分析及生物信息学分析
Mol Med Rep. 2016 Aug;14(2):1162-72. doi: 10.3892/mmr.2016.5349. Epub 2016 May 27.

引用本文的文献

1
Exploring the Proteomic Signature of Diabetic Nephropathy: Implications for Early Diagnosis and Treatment.探索糖尿病肾病的蛋白质组学特征:对早期诊断和治疗的意义。
Life (Basel). 2025 Aug 19;15(8):1312. doi: 10.3390/life15081312.
2
Comprehensive analysis reveals the tumor suppressor role of macrophage signature gene FCER1G in hepatocellular carcinoma.综合分析揭示了巨噬细胞标志性基因FCER1G在肝细胞癌中的肿瘤抑制作用。
Sci Rep. 2025 Feb 1;15(1):3995. doi: 10.1038/s41598-025-88071-8.
3
Developing an advanced diagnostic model for hepatocellular carcinoma through multi-omics integration leveraging diverse cell-death patterns.

本文引用的文献

1
clusterProfiler 4.0: A universal enrichment tool for interpreting omics data.clusterProfiler 4.0:用于解释组学数据的通用富集工具。
Innovation (Camb). 2021 Jul 1;2(3):100141. doi: 10.1016/j.xinn.2021.100141. eCollection 2021 Aug 28.
2
Recent therapeutic targets in diabetic nephropathy.糖尿病肾病的近期治疗靶点。
Int J Clin Pract. 2021 Nov;75(11):e14650. doi: 10.1111/ijcp.14650. Epub 2021 Aug 10.
3
Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment.糖尿病肾病:发病机制、诊断和治疗的挑战。
通过整合多种细胞死亡模式的多组学方法开发用于肝细胞癌的先进诊断模型。
Front Immunol. 2024 Jul 9;15:1410603. doi: 10.3389/fimmu.2024.1410603. eCollection 2024.
4
Evidence of a pan-tissue decline in stemness during human aging.人类衰老过程中干细胞特性在全组织范围内衰退的证据。
Aging (Albany NY). 2024 Apr 4;16(7):5796-5810. doi: 10.18632/aging.205717.
5
The Role of Immune Cells in DKD: Mechanisms and Targeted Therapies.免疫细胞在糖尿病肾病中的作用:机制与靶向治疗
J Inflamm Res. 2024 Apr 6;17:2103-2118. doi: 10.2147/JIR.S457526. eCollection 2024.
Biomed Res Int. 2021 Jul 8;2021:1497449. doi: 10.1155/2021/1497449. eCollection 2021.
4
Role of myeloperoxidase and oxidant formation in the extracellular environment in inflammation-induced tissue damage.髓过氧化物酶和氧化剂形成在炎症诱导的组织损伤中外环境中的作用。
Free Radic Biol Med. 2021 Aug 20;172:633-651. doi: 10.1016/j.freeradbiomed.2021.07.007. Epub 2021 Jul 8.
5
Epigenetics and Inflammation in Diabetic Nephropathy.糖尿病肾病中的表观遗传学与炎症
Front Physiol. 2021 May 5;12:649587. doi: 10.3389/fphys.2021.649587. eCollection 2021.
6
TRUST4: immune repertoire reconstruction from bulk and single-cell RNA-seq data.TRUST4:从批量和单细胞 RNA-seq 数据重建免疫受体库。
Nat Methods. 2021 Jun;18(6):627-630. doi: 10.1038/s41592-021-01142-2. Epub 2021 May 13.
7
Correlations between stemness indices for hepatocellular carcinoma, clinical characteristics, and prognosis.肝细胞癌干性指数、临床特征与预后之间的相关性。
Am J Transl Res. 2020 Sep 15;12(9):5496-5510. eCollection 2020.
8
Crosstalk between tubular epithelial cells and glomerular endothelial cells in diabetic kidney disease.糖尿病肾病中肾小管上皮细胞与肾小球内皮细胞的相互作用。
Cell Prolif. 2020 Mar;53(3):e12763. doi: 10.1111/cpr.12763. Epub 2020 Jan 11.
9
Diabetic Nephropathy: An Overview.糖尿病肾病概述
Methods Mol Biol. 2020;2067:3-7. doi: 10.1007/978-1-4939-9841-8_1.
10
Spatiotemporal immune zonation of the human kidney.人类肾脏的时空免疫分区。
Science. 2019 Sep 27;365(6460):1461-1466. doi: 10.1126/science.aat5031.